the pharmacokinetics of angiotension converting enzyme ( ace ) inhibitors enalapril ( 10 mg orally ) and its active metabolite , enalaprilat ( 10 mg intravenously ) were studied in nine young healthy volunteers aged 22-30 years and nine sex matched elderly subjects aged 65-73 years .
C0014025
enalapril
C0014027
enalaprilat